ethyl 5-amino-3-methylisoxazole-4-carboxylate, 95.0%, 500mg

(2E)-1-(2,4-dimethoxyphenyl)-3-(4-fluorophenyl)prop-2-en-1-one, 95.0%, 2g

(R)-Dimethyl 2-aminopentanedioate hydrochloride, 95.0%, 1g

3-Bromopyrazine-2-carboxamide, 97%, 250mg

4,5,6,7-Tetrahydro-benzo[ d ]isoxazole-3-carboxylic acid, 95.0%, 10g

Éther diisopropylique, min 98 %, pour la synthèse, stab., 2,5 l, emballage en verre

(2e)-3-{4-[(2-methyl-1,3-thiazol-4-yl)methoxy]phenyl}prop-2-enoic acid, 98%, 100mg

5-(TRIFLUOROMETHOXY)BICYCLO[4.2.0]OCTA-1,3,5-TRIEN-7-ONE, 95.0%, 250mg

3-(2-Bromophenyl)propionic acid, 98.0%, 100g

Ethyl 2-chloroethanimidoate hydrochloride, 95.0%, 500mg

cis-5-Octen-1-ol>90.0%(GC)5mL

Solution tampon pH 4,62 ±0,02 (20 °C), ROTI®Calipure prête à l'emploi, 1 l, emballage plastique.

Trimethylolpropane Tris[3-(aziridin-1-yl)propionate]>90.0%(N)25g